Filana Therapeutics Announces Publication in Epilepsia of Preclinical Simufilam Data

Study in a well-accepted mouse model of severe Tuberous Sclerosis Complex (TSC) showed that simufilam attenuated the progression of seizures in a dose-dependent manner Results confirm and extend previously published preclinical findings TSC-related epilepsy affects approximately 45,000 people in